» Articles » PMID: 23664890

Multifunctional Superparamagnetic Iron Oxide Nanoparticles: Promising Tools in Cancer Theranostics

Overview
Journal Cancer Lett
Specialty Oncology
Date 2013 May 14
PMID 23664890
Citations 54
Authors
Affiliations
Soon will be listed here.
Abstract

Iron-oxide nanoparticles of small dimensions that have superparamagnetic properties show immense potential to revolutionize the future of cancer theranostics, the combinatorial diagnosis and therapeutic approach towards cancer. Superparamagnetic iron-oxide nanoparticles (SPIONs) have unique magnetic properties, due to which they show excellent tumor-targeting efficiency, and this paves the way for effective personalized cancer treatment. The aim of this review is to focus on the ability of SPIONs to perform multiple roles in the field of cancer biology, such as in diagnosis, monitoring, targeting and therapy. Also, other topics are discussed, including the synthesis of SPIONs, the challenges and recent advances.

Citing Articles

The Application of Nanoparticles Targeting Cancer-Associated Fibroblasts.

Huang Q, Ge Y, He Y, Wu J, Tong Y, Shang H Int J Nanomedicine. 2024; 19:3333-3365.

PMID: 38617796 PMC: 11012801. DOI: 10.2147/IJN.S447350.


Recent advances in nanomaterial-based drug delivery systems for melanoma therapy.

Parhi R, Kaishap P, Jena G ADMET DMPK. 2024; 12(1):107-150.

PMID: 38560710 PMC: 10974823. DOI: 10.5599/admet.2088.


Smart nanogels for cancer treatment from the perspective of functional groups.

Yu J, Liu Y, Zhang Y, Ran R, Kong Z, Zhao D Front Bioeng Biotechnol. 2024; 11:1329311.

PMID: 38268937 PMC: 10806105. DOI: 10.3389/fbioe.2023.1329311.


Nanoparticle-based materials in anticancer drug delivery: Current and future prospects.

Ajith S, Almomani F, Elhissi A, Husseini G Heliyon. 2023; 9(11):e21227.

PMID: 37954330 PMC: 10637937. DOI: 10.1016/j.heliyon.2023.e21227.


Smart nanoparticles for cancer therapy.

Sun L, Liu H, Ye Y, Lei Y, Islam R, Tan S Signal Transduct Target Ther. 2023; 8(1):418.

PMID: 37919282 PMC: 10622502. DOI: 10.1038/s41392-023-01642-x.